Aduro Clean Technologies Reports 2024 Financial Results and Provides End of Year Update
12 sept. 2024 07h00 HE
|
Aduro Clean Technologies Inc.
Aduro Clean Technologies Reports 2024 Financial Results and Provides End of Year Update
Aduro Clean Technologies files new patent application to transform waste plastics and renewable oils into high value BTX chemicals
04 sept. 2024 07h00 HE
|
Aduro Clean Technologies Inc.
Aduro announced a new patent filing covering a new technology for transforming renewable oils and certain waste plastics into higher-value BTX chemicals.
Aduro Clean Technologies Presents at CEM Scottsdale Capital Event
11 avr. 2023 07h00 HE
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, April 11, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Clean Technologies Announces Participation in Key Industry Conferences
16 févr. 2023 07h00 HE
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Announces Grant of Stock Options and RSUs
29 déc. 2022 20h30 HE
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Announces Stock Option Grants
20 juin 2022 19h32 HE
|
Aduro Clean Technologies Inc.
SARNIA, Ontario, June 20, 2022 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQB: ACTHF) (FSE: 9D50), a Canadian developer of patented water-based...
Aduro Biotech, Inc. (Nasdaq: ADRO) to Ring The Nasdaq Stock Market Opening Bell
27 mars 2017 10h00 HE
|
NASDAQ, Inc.
ADVISORY, March 27, 2017 (GLOBE NEWSWIRE) -- What:Aduro Biotech, Inc. (Nasdaq:ADRO), an immunotherapy company focused on the discovery, development and commercialization of therapies that...
Aduro Biotech Appoints Liana Wu as Vice President of Commercial
02 juin 2015 08h00 HE
|
Chinook Therapeutics, Inc.
BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...
Aduro Biotech Announces ASCO Presentation of Encouraging Data From Ongoing Phase 1b Clinical Trial of Its Immunotherapy for the Treatment of Mesothelioma
01 juin 2015 09h00 HE
|
Chinook Therapeutics, Inc.
BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...
Aduro Biotech Announces First Quarter 2015 Financial Results
28 mai 2015 16h00 HE
|
Chinook Therapeutics, Inc.
Established major $750M collaboration with Novartis for STING in oncology
Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...